Lupin Limited Secures US FDA Approval for Generic Brivaracetam Oral Solution
Lupin has received US FDA approval for its generic brivaracetam oral solution, bioequivalent to Briviact, and has launched the product in the US market targeting partial-onset seizures.
Brivaracetam Oral Solution | 25/02/2026 | By News Bureau
Indoco Remedies Secures US FDA Approval for Generic Brivaracetam Oral Solution
Indoco Remedies receives US FDA approval to market generic brivaracetam oral solution for partial-onset seizures in the US market.
Brivaracetam Oral Solution | 24/02/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy